CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
57.28
-1.12 (-1.92%)
Jan 6, 2026, 4:00 PM EST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $55.18 billion as of January 7, 2026. Its market cap has decreased by -34.11% in one year.
Market Cap
55.18B
Enterprise Value
66.90B
Revenue
15.56B
Ranking
n/a
PE Ratio
18.38
Stock Price
$57.28
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 55.18B, an increase of 23,875.61%. That is a compound annual growth rate of 18.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 54.63B | -1.61% |
| Dec 31, 2025 | 55.52B | -34.20% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |